Pharm R3
GLP-3R triple agonist · Metabolic & cellular research
This product is sold strictly for in-vitro laboratory research. Not for human or veterinary consumption, ingestion, inhalation, or topical application. Has not been evaluated by the FDA. Buyer must be a qualified researcher 21+ years of age.
Verified lyophilized powder for in-vitro research.
Triple-agonist research peptide acting on GLP-1, GIP, and glucagon receptors. Used in lab investigation of metabolic and cellular pathways.
Analytical reference.
Lab-grade handling guidance.
- Storage temperature: Lyophilized vials are stable at -20°C in a controlled-access laboratory freezer. Short-term storage at 4°C is acceptable for vials in active use.
- Stability: Refer to the included Safety Data Sheet (SDS) for material-specific stability windows.
- PPE & safety: Standard laboratory PPE (gloves, eye protection, lab coat) required. Avoid skin contact, ingestion, and inhalation.
- Disposal: Dispose of products and packaging in accordance with applicable environmental and biohazard regulations.
Documented from synthesis to your bench.
-
Sealed lyophilized vialSingle-use sterile vial sealed under nitrogen
-
Lot-specific Certificate of AnalysisHPLC purity + Mass Spec identity confirmation
-
Safety Data Sheet (SDS)Storage, handling, and disposal guidance
-
Cold-chain insulated packagingIce packs included for lyophilized compounds
Sequence.
GLP-3R / LY3437943 — triple-agonist (Retatrutide-class)